Spyre Therapeutics, Inc. SYRE

SYRE

Spyre Therapeutics, Inc.

Exchange: nyse

Multiples

P/E: -6.14
P/BV: 6.56
P/TBV: 7.18

Description:

none

Data:

Market Cap

1320569984.00

EBITDA

-194508992.00

Net Income

Yields:

Earnings Yield

0.469571028752

Return on Capital

CAGR (net income)

0%

CAGR Length

0

Dividend Rate